Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Odonate Therapeutics, Inc. (ODT)
Sector: Healthcare; Industry: Biotechnology

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with locally advanced or metastatic breast cancer; and CONTESSA 2 and CONTESSA TRIO, which is in Phase II clinical study for central nervous system metastases and various cancer treatments.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-09-29 Davis Aaron I. 10%-Owner, Director Buy 215,200 $13.63 $2,932,156 No
2020-09-29 Boxer Capital, LLC 10%-Owner, Director Buy 215,200 $13.63 $2,932,156 No
2020-09-29 TANG KEVIN C Chief Executive Officer Buy 110,882 $13.13 $1,456,408 No
2020-09-09 Davis Aaron I. 10%-Owner, Director Buy 225,000 $14.99 $3,371,631 No
2020-09-09 Boxer Capital, LLC 10%-Owner, Director Buy 225,000 $14.99 $3,371,631 No
2020-08-28 Boxer Capital, LLC 10%-Owner, Director Buy 1,403,509 $14.25 $20,000,003 No
2020-08-28 Davis Aaron I. 10%-Owner, Director Buy 1,403,509 $14.25 $20,000,003 No
2020-08-28 TANG KEVIN C Chief Executive Officer Buy 1,052,631 $14.25 $14,999,992 No
2019-06-26 Boxer Capital, LLC 10%-Owner Buy 384,615 $26.00 $9,999,990 No
2019-06-26 Vacirca Jeff L Director Buy 19,231 $26.00 $500,006 No
2019-06-26 TANG KEVIN C Chief Executive Officer Buy 769,231 $26.00 $20,000,006 No
2019-06-18 TANG KEVIN C Chief Executive Officer Buy 50,000 $26.15 $1,307,546 No
2019-06-07 TANG KEVIN C Chief Executive Officer Buy 76,308 $27.36 $2,087,457 No
2019-06-05 TANG KEVIN C Chief Executive Officer Buy 93,692 $24.92 $2,335,217 No
2019-03-08 TANG KEVIN C Chief Executive Officer Buy 140,000 $18.26 $2,556,316 No
2019-03-04 Vacirca Jeff L Director Buy 3,000 $17.00 $51,000 No
2018-12-31 TANG KEVIN C Chief Executive Officer Buy 63,700 $13.11 $835,107 No
2018-12-26 Davis Aaron I. 10%-Owner, Director Buy 125,000 $13.27 $1,658,830 No
2018-12-26 Boxer Capital, LLC 10%-Owner, Director Buy 125,000 $13.27 $1,658,830 No
2018-12-26 TANG KEVIN C Chief Executive Officer Buy 60,000 $12.60 $755,857 No
2018-12-18 TANG KEVIN C Chief Executive Officer Buy 40,000 $14.67 $586,639 No
2018-12-12 TANG KEVIN C Chief Executive Officer Buy 20,000 $15.60 $312,073 No
2018-12-07 TANG KEVIN C Chief Executive Officer Buy 20,000 $14.79 $295,864 No
2018-11-27 TANG KEVIN C Chief Executive Officer Buy 3,063 $15.64 $47,912 No
2018-11-26 TANG KEVIN C Chief Executive Officer Buy 16,937 $15.29 $259,017 No
2018-11-01 TANG KEVIN C Chief Executive Officer Buy 10,000 $14.87 $148,727 No
2018-10-29 TANG KEVIN C Chief Executive Officer Buy 10,235 $14.98 $153,367 No
2018-10-24 Davis Aaron I. 10%-Owner, Director Buy 26,824 $14.72 $394,753 No
2018-10-24 Boxer Capital, LLC 10%-Owner, Director Buy 26,824 $14.72 $394,753 No
2018-10-25 TANG KEVIN C Chief Executive Officer Buy 39,765 $15.35 $610,301 No

Insider Smart

Axsome Therapeutics, Inc (AXSM) - AXSM shows the power of an #allgreen stock, no insider selling, great management great company, if you follow the insiders last year and pick up around $25, the 52 week high is $100+.

Insider Smart

SYSCO CORP (SYY) - PELTZ NELSON and Frank Joshua D are insiders of SYSCO CORP, check their transactions to see how they sell high and buy low. Would that be more persuasive than just buy or sell?